Drug: HEPARIN Injury: Cardiac failure Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 126647502 | HEPARIN | Cardiac failure | SANDOZ | 50.00 YR | M | 0 | 20160913 | GB |
| 126705604 | HEPARIN | Cardiac failure | BRISTOL MYERS SQUIBB | 50.91 YR | M | 0 | 20160928 | GB |
| 126735161 | HEPARIN | Cardiac failure | SANDOZ | 50.00 YR | M | 0 | 20160822 | GB |
| 126829721 | HEPARIN | Cardiac failure | AUROBINDO | 0.00 | M | 0 | 20160825 | GB |
| 126830531 | HEPARIN | Cardiac failure | TEVA | 0.00 | M | 0 | 20160825 | GB |
| 126918402 | HEPARIN | Cardiac failure | INTERNATIONAL MEDICATION SYSTEM | 50.00 YR | M | 0 | 20160927 | GB |
| 127619661 | HEPARIN | Cardiac failure | AUROBINDO | 50.00 YR | M | 0 | 20160920 | GB |
Total Records: 7 Number of Pages: 1